Similar findings were reported by Masselli et al. [24] who observed no detectable differences in the −2518 A/G SNP (CCL2 rs1024611) genotypic and allelic frequencies of overall MPN, PV, ET, and MF patients vs. control subjects, as well as between single disease entities. This evidence concerns the gene CCL2 and essential thrombocythemia.